PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,181,000 | -39.5% | 1,233,657 | -9.7% | 0.01% | -30.0% |
| Q3 2018 | $8,564,000 | +51.3% | 1,365,834 | +94.0% | 0.01% | +25.0% |
| Q2 2018 | $5,659,000 | +37626.7% | 703,900 | +35831.6% | 0.01% | – |
| Q1 2018 | $15,000 | -76.6% | 1,959 | -81.8% | 0.00% | – |
| Q4 2017 | $64,000 | +357.1% | 10,752 | +448.9% | 0.00% | – |
| Q3 2017 | $14,000 | -91.5% | 1,959 | -92.5% | 0.00% | – |
| Q3 2016 | $165,000 | – | 26,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|